United States · FDA National Drug Code directory
ESLICARBAZEPINE ACETATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-536_2067fb77-9657-44da-b430-02e8a4efacb5
- Product NDC
- 59651-536
- Form
- TABLET
- Composition / generic term
- ESLICARBAZEPINE ACETATE
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260805
- Source listing expiry
- 20271231
Source-listed ingredients
- ESLICARBAZEPINE ACETATE — 800 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (59651-536-30) · 59651-536-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →